SKYE · Categories · Form 4

SKYE - SEC Form 4 insider transactions

Skye Bioscience Inc. (SKYE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SKYE

• 28d
  SEC Form 4 filed by Smith Karen L.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Twitty Christopher

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Jenkins Annalisa

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Charych Deborah H.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Grayson Paul A.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Schwab Andrew J.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Diep Tuan Tu

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 28d
  SEC Form 4 filed by Dhillon Punit

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Director Grayson Paul A.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Chief Financial Officer Arsenault Kaitlyn

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Director Smith Karen L.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Chief Scientific Officer Twitty Christopher

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Chief Development Officer Diep Tuan Tu

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Director Jenkins Annalisa

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Director Charych Deborah H.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Chief Medical Officer Arora Puneet S.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 80d
  SEC Form 4 filed by Chief Executive Officer Dhillon Punit

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 251d
  Director Schwab Andrew J. sold $800,548 worth of shares (231,405 units at $3.46) (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 251d
  Large owner 5am Partners Vii, Llc sold $800,548 worth of shares (231,405 units at $3.46) (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 426d
  Amendment: Chief Financial Officer Arsenault Kaitlyn sold $215,754 worth of shares (43,216 units at $4.99), decreasing direct ownership by 21% to 167,522 units (SEC Form 4)

  4/A - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Chief Financial Officer Arsenault Kaitlyn

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Director Jenkins Annalisa

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Director Grayson Paul A.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Director Smith Karen L.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Chief Executive Officer Dhillon Punit

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Director Charych Deborah H.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Chief Development Officer Diep Tuan Tu

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 428d
  SEC Form 4 filed by Chief Medical Officer Arora Puneet S.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 526d
  Chief Development Officer Diep Tuan Tu sold $97,722 worth of shares (19,574 units at $4.99), decreasing direct ownership by 19% to 82,259 units (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 527d
  Chief Financial Officer Arsenault Kaitlyn sold $216,652 worth of shares (43,396 units at $4.99), decreasing direct ownership by 21% to 166,342 units (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 527d
  Chief Executive Officer Dhillon Punit sold $413,925 worth of shares (82,910 units at $4.99), decreasing direct ownership by 20% to 329,823 units (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 527d
  Director Grayson Paul A. sold $432,061 worth of shares (86,551 units at $4.99), decreasing direct ownership by 25% to 259,701 units (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Chief Development Officer Diep Tuan Tu

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Chief Financial Officer Arsenault Kaitlyn

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Chief Executive Officer Dhillon Punit

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Director Grayson Paul A.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Director Smith Karen L.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Director Charych Deborah H.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 547d
  SEC Form 4 filed by Director Jenkins Annalisa

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 594d
  Director Schwab Andrew J. sold $1,750,352 worth of shares (266,337 units at $6.57) (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 594d
  Large owner 5am Partners Vii, Llc sold $1,750,352 worth of shares (266,337 units at $6.57) (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 603d
  SEC Form 4 filed by Chief Medical Officer Arora Puneet S.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 611d
  Chief Executive Officer Dhillon Punit acquired 15,727 shares, increasing direct ownership by 4% to 412,733 units (SEC Form 4)

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)
• 664d
  SEC Form 4 filed by Director Smith Karen L.

  4 - Skye Bioscience, Inc. (0001516551) (Issuer)

Other SKYE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends